The protein encoded by CDKN1B is found to bind to and prevent the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, therefore controls the cell cycle progression at G1 and its polymorphism appears to be an important predictive factor for breast cancer risk [28]. Here, CDK4 is linked to breast carcinoma.